(Q33335306)

English

Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1 reference

based on heuristic

inferred from title

2

object named as

Storb R

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Hans Joachim Deeg

5

object named as

Deeg HJ

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Frederick R. Appelbaum

4

object named as

Appelbaum FR

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

author name string

Furlong T

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Anasetti C

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Doney K

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Martin P

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Sullivan K

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Witherspoon R

9

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Nash RA

10

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

language of work or name

0 references

publication date

1 November 2000

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

985-991

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702639

0 references

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702639

21 January 2018

Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702639

21 January 2018

Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702639

21 January 2018

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702639

21 January 2018

A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702639

21 January 2018

FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702639

21 January 2018

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702639

21 January 2018

Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702639

21 January 2018

Cyclosporin A, methylprednisolone, and convulsions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702639

21 January 2018

Cyclosporin, methylprednisolone, and convulsions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702639

21 January 2018

Plasma exchange and vincristine in the treatment of hemolytic uremic syndrome/thrombotic thrombocytopenic purpura associated with bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702639

21 January 2018

Cyclosporin A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: three distinct syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702639

21 January 2018

Thrombotic microangiopathic syndromes after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702639

21 January 2018

Haemolytic uraemic syndrome during FK506 therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702639

21 January 2018

Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702639

21 January 2018

Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702639

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702639

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702639

7 January 2021

based on heuristic

inferred from DOI database lookup

Normal pancreas allograft function following simultaneous pancreas kidney transplantation after rescue therapy with tacrolimus (FK506)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702639

7 January 2021

based on heuristic

inferred from DOI database lookup

Rescue therapy with tacrolimus after combined kidney/pancreas and isolated pancreas transplantation in patients with severe cyclosporine nephrotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702639

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702639

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between cyclosporin neurotoxicity and hypomagnesaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702639

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclosporin-associated central nervous system toxicity after allogeneic bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702639

7 January 2021

based on heuristic

inferred from DOI database lookup

Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thromboses and tubular injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702639

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1702639

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33335306&oldid=1958158851"